Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Agrawal, Anurodh Shankar ^a   Ying, Tianlei ^b   Tao, Xinrong ^a   Garron, Tania ^a   Algaissi, Abdullah ^a,c   Wang, Yanping ^d   Wang, Lili ^d   Peng, Bi Hung ^e   Jiang, Shibo ^c   Dimitrov, Dimiter S ^d   Tseng, Chien Te K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b FUDAN UNIVERSITY   (China)

^c JAZAN UNIVERSITY   (Saudi Arabia)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ANIMAL; CORONAVIRUS INFECTION; HUMAN; IMMUNOLOGY; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MOUSE; PASSIVE IMMUNIZATION; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CORONAVIRUS INFECTIONS; HUMANS; IMMUNIZATION, PASSIVE; MICE; MICE, TRANSGENIC; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS;

EID: 84983334840     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep31629     Document Type: Article

References (46)

1. Chan, J. F. et al. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARSlike pandemic? J Infect 65, 477-489, doi: 10.1016/j.jinf.2012.10.002 (2012).
2. Assiri, A. et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 369, 407-416, doi: 10.1056/NEJMoa1306742 (2013).
3. Memish, Z. A. et al. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis 19, 1819-1823, doi: 10.3201/eid1911.131172 (2013).
4. Cotten, M. et al. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: A descriptive genomic study. Lancet 382, 1993-2002, doi: 10.1016/S0140-6736(13)61887-5 (2013).
5. Lau, S. K. et al. Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus. J Virol 87, 8638-8650, doi: 10.1128/JVI.01055-13 (2013).
6. van Boheemen, S. et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 3, doi: 10.1128/mBio.00473-12 (2012).
7. Woo, P. C., Lau, S. K., Li, K. S., Tsang, A. K. & Yuen, K. Y. Genetic relatedness of the novel human group C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5. Emerg Microbes Infect 1, e35, doi: 10.1038/emi.2012.45 (2012).
8. Woo, P. C. et al. Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features. J Virol 81, 1574-1585, doi: 10.1128/JVI.02182-06 (2007).
9. Azhar, E. I. et al. Evidence for camel-To-human transmission of MERS coronavirus. N Engl J Med 370, 2499-2505, doi: 10.1056/NEJMoa1401505 (2014).
10. Haagmans, B. L. et al. Middle East respiratory syndrome coronavirus in dromedary camels: An outbreak investigation. Lancet Infect Dis 14, 140-145, doi: 10.1016/S1473-3099(13)70690-X (2014).
11. Alagaili, A. N. et al. Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. MBio 5, e00884-00814, doi: 10.1128/mBio.00884-14 (2014).
12. Meyer, B. et al. Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis 20, 552-559, doi: 10.3201/eid2004.131746 (2014).
13. Chu, D. K. et al. Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria, 2015. Euro Surveill 20, doi: 10.2807/1560-7917.ES.2015.20.49.30086 (2015).
14. Chu, D. K. et al. MERS coronaviruses in dromedary camels, Egypt. Emerg Infect Dis 20, 1049-1053, doi: 10.3201/eid2006.140299 (2014).
15. Sabir, J. S. et al. Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia. Science 351, 81-84, doi: 10.1126/science.aac8608 (2016).
16. Memish, Z. A., Zumla, A. I., Al-Hakeem, R. F., Al-Rabeeah, A. A. & Stephens, G. M. Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med 368, 2487-2494, doi: 10.1056/NEJMoa1303729 (2013).
17. Park, Y. S. et al. The first case of the 2015 Korean Middle East Respiratory Syndrome outbreak. Epidemiol Health 37, e2015049, doi: 10.4178/epih/e2015049 (2015).
18. Korea Centers for Disease, C. & Prevention. Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015. Osong Public Health Res Perspect 6, 269-278, doi: 10.1016/j.phrp.2015.08.006 (2015).
19. Bin, S. Y. et al. Environmental Contamination and Viral Shedding in MERS Patients During MERS-CoV Outbreak in South Korea. Clin Infect Dis 62, 755-760, doi: 10.1093/cid/civ1020 (2016).
20. Raj, V. S. et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495, 251-254, doi: 10.1038/nature12005 (2013).
21. Lu, G. et al. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature 500, 227-231, doi: 10.1038/nature12328 (2013).
22. Wang, N. et al. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res 23, 986-993, doi: 10.1038/cr.2013.92 (2013).
23. Ying, T. et al. Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies. J Virol 88, 7796-7805, doi: 10.1128/JVI.00912-14 (2014).
24. Jiang, L. et al. Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein. Sci Transl Med 6, 234ra259, doi: 10.1126/scitranslmed.3008140 (2014).
25. Du, L. et al. A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein. J Virol 88, 7045-7053, doi: 10.1128/JVI.00433-14 (2014).
26. Tang, X. C. et al. Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution. Proc Natl Acad Sci USA 111, E2018-2026, doi: 10.1073/pnas.1402074111 (2014).
27. Corti, D. et al. Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus. Proc Natl Acad Sci USA 112, 10473-10478, doi: 10.1073/pnas.1510199112 (2015).
28. Pascal, K. E. et al. Pre-And postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection. Proc Natl Acad Sci USA 112, 8738-8743, doi: 10.1073/pnas.1510830112 (2015).
29. Ying, T. et al. Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germlinelike antibody. Nat Commun 6, 8223, doi: 10.1038/ncomms9223 (2015).
30. Falzarano, D. et al. Infection with MERS-CoV causes lethal pneumonia in the common marmoset. PLoS Pathog 10, e1004250, doi: 10.1371/journal.ppat.1004250 (2014).
31. Haagmans, B. L. et al. Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits. J Virol 89, 6131-6135, doi: 10.1128/JVI.00661-15 (2015).
32. Houser, K. V. et al. Prophylaxis with a MERS-CoV-specific human monoclonal antibody protects rabbits from MERS-CoV infection. J Infect Dis, doi: 10.1093/infdis/jiw080 (2016).
33. Zhao, J. et al. Rapid generation of a mouse model for Middle East respiratory syndrome. Proc Natl Acad Sci USA 111, 4970-4975, doi: 10.1073/pnas.1323279111 (2014).
34. Agrawal, A. S. et al. Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease. J Virol 89, 3659-3670, doi: 10.1128/JVI.03427-14 (2015).
35. van Doremalen, N. & Munster, V. J. Animal models of Middle East respiratory syndrome coronavirus infection. Antiviral Res 122, 28-38, doi: 10.1016/j.antiviral.2015.07.005 (2015).
36. Li, Y. et al. A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein. Cell Res 25, 1237-1249, doi: 10.1038/cr.2015.113 (2015).
37. Luke, T. et al. Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo. Sci Transl Med 8, 326ra321, doi: 10.1126/scitranslmed.aaf1061 (2016).
38. Tao, X. et al. Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease. J Virol 90, 57-67, doi: 10.1128/JVI.02009-15 (2015).
39. Marasco, W. A. & Sui, J. The growth and potential of human antiviral monoclonal antibody therapeutics. Nat Biotechnol 25, 1421-1434, doi: 10.1038/nbt1363 (2007).
40. Du, L. et al. The spike protein of SARS-CoV-A target for vaccine and therapeutic development. Nat Rev Microbiol 7, 226-236, doi: 10.1038/nrmicro2090 (2009).
41. Keller, M. A. & Stiehm, E. R. Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev 13, 602-614 (2000).
42. Couderc, T. et al. Prophylaxis and therapy for Chikungunya virus infection. J Infect Dis 200, 516-523, doi: 10.1086/600381 (2009).
43. Chippaux, J. P., Boyer, L. V. & Alagon, A. Post-exposure treatment of Ebola virus using passive immunotherapy: proposal for a new strategy. J Venom Anim Toxins Incl Trop Dis 21, 3, doi: 10.1186/s40409-015-0003-1 (2015).
44. Lu, L. et al. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat Commun 5, 3067, doi: 10.1038/ncomms4067 (2014).
45. Malczyk, A. H. et al. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform. J Virol 89, 11654-11667, doi: 10.1128/JVI.01815-15 (2015).
46. Tseng, C. T. et al. Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor. J Virol 81, 1162-1173, doi: 10.1128/JVI.01702-06 (2007).